Clinical Trials Directory

Trials / Completed

CompletedNCT06966037

Uric Acid Levels and Migraine in Children

Evaluation of Uric Acid Levels in Pediatric Patients With Migraine

Status
Completed
Phase
Study type
Observational
Enrollment
2 (actual)
Sponsor
Aysen Orman · Academic / Other
Sex
All
Age
6 Years – 18 Years
Healthy volunteers
Accepted

Summary

Migraine is recognized as one of the most prevalent neurological disorders. The exact pathophysiological mechanisms underlying migraine have not yet been fully elucidated. The present study aims to compare serum uric acid levels between pediatric patients with migraine and a control group. Additionally, this study seeks to explore the potential relationship between migraine attack frequency and gender differences in pediatric patients

Detailed description

Migraine is recognized as one of the most prevalent neurological disorders. The exact pathophysiological mechanisms underlying migraine have not yet been fully elucidated. The present study aims to compare serum uric acid levels between pediatric patients with migraine and a control group. Additionally, this study seeks to explore the potential relationship between migraine attack frequency and gender differences in pediatric patients Patients diagnosed with migraine were included as the study group, while the control group consisted of patients who presented to the pediatric neurology clinic during the same period for neuromotor development follow-up examinations. Migraine patients are influenced by multiple factors, including dietary habits, levels of physical activity, and various psychosocial determinants.

Conditions

Timeline

Start date
2019-08-01
Primary completion
2025-01-01
Completion
2025-04-01
First posted
2025-05-11
Last updated
2025-05-11

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06966037. Inclusion in this directory is not an endorsement.